Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,213 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · derivative · entry 10 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,213 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option to purchase 46,664 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 46,664 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 427 | $247.08 | $105,503.16 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,930 F5 · price: Price reflects a weighted average sale price for multiple transactions ranging from $246.4675 to $247.44 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 5,985 | $245.79 | $1,471,053.15 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 6 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,357 F4 · price: Price reflects a weighted average sale price for multiple transactions ranging from $245.43 to $246.405 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 3,485 | $244.55 | $852,256.75 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,342 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $244.14 to $245.105 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 10,316 | $243.53 | $2,512,255.48 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,827 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $243.08 to $244.07 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 16, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 20,213 | $114.22 | $2,308,728.86 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 63,143 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,119 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · derivative · entry 9 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,213 Underlying: Ordinary Shares · 3,119 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: This option to purchase 46,664 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 46,664 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 3,119 | $248.02 | $773,574.38 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,930 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $248.00 to $248.08 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 13, 2024 Filed Sep 17, 2024 20:30 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 3,119 | $114.22 | $356,252.18 |
DisclosureSEC source: 0001628280-24-040611 · wk-form4_1726605032.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 46,049 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 23,332 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-24-040240 · wk-form4_1726173088.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,332 Underlying: Ordinary Shares · 23,332 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 46,664 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 46,664 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 23,332 | $247.00 | $5,763,004.00 |
DisclosureSEC source: 0001628280-24-040240 · wk-form4_1726173088.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 42,930 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $247.00 to $247.31 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of September 10, 2024, 8,286 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 432 on October 1, 2024; 1,293 on June 2, 2025; 573 on June 2, 2025; 564 on June 2, 2025; 1,141 on June 4, 2025; 144 on October 1, 2025; 1,293 on June 1, 2026; 564 on June 2, 2026; 1,141 on June 4, 2026 and 1,141 on June 4, 2027. Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 20:31 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 23,332 | $114.22 | $2,664,981.04 |
DisclosureSEC source: 0001628280-24-040240 · wk-form4_1726173088.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,262 Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:39 UTC |
Steeves Richard MartinDirector
|
GrantCareer Restricted Stock Units · Derivative | 358 | $239.68 | $85,805.44 |
DisclosureSEC source: 0001628280-24-036803 · wk-form4_1723495134.xml · derivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,063 Underlying: Ordinary Shares · 358 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $86,000. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:39 UTC |
Steeves Richard MartinDirector
|
GrantCareer Restricted Stock Units · Derivative | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036803 · wk-form4_1723495134.xml · derivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,705 Underlying: Ordinary Shares · 495 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:39 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 175 | $85.34 Strike: $239.68 | $14,934.50 |
DisclosureSEC source: 0001628280-24-036803 · wk-form4_1723495134.xml · derivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,564 Underlying: Ordinary Shares · 175 shares Expires 2034-08-08 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $15,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:39 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,389 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036803 · wk-form4_1723495134.xml · derivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389 Underlying: Ordinary Shares · 1,389 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:38 UTC |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 95 | $239.68 | $22,769.60 |
DisclosureSEC source: 0001628280-24-036801 · wk-form4_1723495093.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,151 Underlying: Ordinary Shares · 95 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $23,000. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:38 UTC |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 783 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036801 · wk-form4_1723495093.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,056 Underlying: Ordinary Shares · 783 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:38 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 2,197 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036801 · wk-form4_1723495093.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,197 Underlying: Ordinary Shares · 2,197 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:35 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantCareer Restricted Stock Units · Derivative | 442 | $239.68 | $105,938.56 |
DisclosureSEC source: 0001628280-24-036794 · wk-form4_1723494932.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,988 Underlying: Ordinary Shares · 442 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $106,000 . F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:35 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantCareer Restricted Stock Units · Derivative | 494 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036794 · wk-form4_1723494932.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,546 Underlying: Ordinary Shares · 494 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:35 UTC |
KOSECOFF JACQUELINE BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,388 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036794 · wk-form4_1723494932.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388 Underlying: Ordinary Shares · 1,388 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:37 UTC |
Shah Nirav RDirector
|
GrantCareer Restricted Stock Units · Derivative | 494 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036799 · wk-form4_1723495047.xml · derivative · entry 2 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,016 Underlying: Ordinary Shares · 494 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:37 UTC |
Shah Nirav RDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,388 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036799 · wk-form4_1723495047.xml · derivative · entry 1 Shah Nirav R · CIK 0001740213 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388 Underlying: Ordinary Shares · 1,388 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:36 UTC |
Martin Paul EdwardDirector
|
GrantCareer Restricted Stock Units · Derivative | 494 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036796 · wk-form4_1723494979.xml · derivative · entry 2 Martin Paul Edward · CIK 0001700415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,075 Underlying: Ordinary Shares · 494 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:36 UTC |
Martin Paul EdwardDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,388 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036796 · wk-form4_1723494979.xml · derivative · entry 1 Martin Paul Edward · CIK 0001700415 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388 Underlying: Ordinary Shares · 1,388 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:34 UTC |
HOLLAND CHRISTOPHER SDirector
|
SaleOrdinary Shares | 473 | $239.68 | $113,368.64 |
DisclosureSEC source: 0001628280-24-036792 · wk-form4_1723494888.xml · nonDerivative · entry 2 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 582 F1 · shares: 473 shares were withheld from the 988 ordinary shares that were awarded on August 8, 2024These 473 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 988 ordinary shares were awarded to Mr. Holland on August 8, 2024. These shares were valued at the NYSE closing market price on August 8, 2024. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:34 UTC |
HOLLAND CHRISTOPHER SDirector
|
GrantOrdinary Shares | 988 | $239.68 | $236,803.84 |
DisclosureSEC source: 0001628280-24-036792 · wk-form4_1723494888.xml · nonDerivative · entry 1 HOLLAND CHRISTOPHER S · CIK 0001271440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,055 Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:32 UTC |
Breeden Richard CDirector
|
GrantCareer Restricted Stock Units · Derivative | 358 | $239.68 | $85,805.44 |
DisclosureSEC source: 0001628280-24-036785 · wk-form4_1723494771.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,703 Underlying: Ordinary Shares · 358 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $86,000. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:32 UTC |
Breeden Richard CDirector
|
GrantCareer Restricted Stock Units · Derivative | 495 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036785 · wk-form4_1723494771.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,345 Underlying: Ordinary Shares · 495 shares Expires not disclosed F3 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F4 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:32 UTC |
Breeden Richard CDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 292 | $85.34 Strike: $239.68 | $24,919.28 |
DisclosureSEC source: 0001628280-24-036785 · wk-form4_1723494771.xml · derivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,681 Underlying: Ordinary Shares · 292 shares Expires 2034-08-08 F2 · derivative.exercise_price: These nonqualified stock options were issued to the Reporting Person in lieu of fees of $25,000. F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:32 UTC |
Breeden Richard CDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,389 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036785 · wk-form4_1723494771.xml · derivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,389 Underlying: Ordinary Shares · 1,389 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:34 UTC |
FELDMANN CYNTHIA LDirector
|
GrantCareer Restricted Stock Units · Derivative | 494 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036789 · wk-form4_1723494841.xml · derivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,641 Underlying: Ordinary Shares · 494 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:34 UTC |
FELDMANN CYNTHIA LDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 1,388 | $0.00 Strike: $239.68 | $0.00 |
DisclosureSEC source: 0001628280-24-036789 · wk-form4_1723494841.xml · derivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,388 Underlying: Ordinary Shares · 1,388 shares Expires 2034-08-08 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 08, 2024 Filed Aug 12, 2024 20:31 UTC |
Alegria Esther M.Director
|
GrantCareer Restricted Stock Units · Derivative | 988 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-036783 · wk-form4_1723494663.xml · derivative · entry 1 Alegria Esther M. · CIK 0001867056 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,409 Underlying: Ordinary Shares · 988 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 08, 2024 Filed Oct 2, 2024 20:31 UTC Amendment |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 417 | $239.68 | $99,946.56 |
DisclosureSEC source: 0001628280-24-041916 · wk-form4a_1727901066.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,472 Underlying: Ordinary Shares · 417 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · shares: This Form 4 Amendment is being filed to correct the amount of Career Restricted Stock Units previously reported. F4 · price: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $100,000. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · balance_after: This Form 4 Amendment is being filed to correct the amount of Career Restricted Stock Units previously reported. Read SEC document |
| August 08, 2024 Filed Oct 2, 2024 20:31 UTC Amendment |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 782 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-041916 · wk-form4a_1727901066.xml · derivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,055 Underlying: Ordinary Shares · 782 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · shares: This Form 4 Amendment is being filed to correct the amount of Career Restricted Stock Units previously reported. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · balance_after: This Form 4 Amendment is being filed to correct the amount of Career Restricted Stock Units previously reported. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,252 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · derivative · entry 6 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,252 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,252 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,252 ordinary shares for $77.07 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 400 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · derivative · entry 5 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,700 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 2,700 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 2,700 ordinary shares for $69.72 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC |
Madsen JuliaSenior VP, Life Sciences
|
SaleOrdinary Shares | 3,252 | $230.00 | $747,960.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · nonDerivative · entry 4 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,671 F1 · balance_after: As of June 5, 2024, 4,483 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 542 on June 4, 2025, 144 on October 1, 2025; 578 on June 1, 2026, 352 on June 2, 2026 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionOrdinary Shares | 3,252 | $77.07 | $250,631.64 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC |
Madsen JuliaSenior VP, Life Sciences
|
SaleOrdinary Shares | 400 | $230.00 | $92,000.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,671 Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:31 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Exercise / conversionOrdinary Shares | 400 | $69.72 | $27,888.00 |
DisclosureSEC source: 0001628280-24-027295 · wk-form4_1717792263.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,071 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:32 UTC |
Majors Cary LSVP and President, Healthcare
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,932 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-24-027300 · wk-form4_1717792364.xml · derivative · entry 4 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,932 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 14,932 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 14,932 ordinary shares for $114.22 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:32 UTC |
Majors Cary LSVP and President, Healthcare
|
SaleOrdinary Shares | 4,932 | $229.63 | $1,132,535.16 |
DisclosureSEC source: 0001628280-24-027300 · wk-form4_1717792364.xml · nonDerivative · entry 2 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,054 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $229.2550 to $229.9900 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: As of June 4, 2024, 9,872 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,964 on June 2, 2025; 692 on October 1, 2025; 2,697 on June 1, 2026; 2,140 on June 2, 2026 and 2,379 on June 4, 2027. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 20:32 UTC |
Majors Cary LSVP and President, Healthcare
|
Exercise / conversionOrdinary Shares | 4,932 | $114.22 | $563,333.04 |
DisclosureSEC source: 0001628280-24-027300 · wk-form4_1717792364.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 04, 2024 Filed Jun 5, 2024 20:31 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 1,063 | $228.37 | $242,757.31 |
DisclosureSEC source: 0001628280-24-026863 · wk-form4_1717619474.xml · nonDerivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,467 F3 · shares: 1,063 shares were withheld from the 2,369 restricted shares that vested on June 3, 2024. These 1,063 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,369 ordinary shares were awarded to Mr. Carestio on June 2, 2022. These vested shares were valued at the NYSE closing market price on June 3, 2024. F4 · balance_after: As of June 3, 2024, 15,446 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 289 on October 1, 2024; 4,308 on June 2, 2025; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025; 4,308 on June 1, 2026 and 2,369 on June 2, 2026. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
GrantEmployee Stock Option (right to buy) · Derivative | 8,336 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027069 · wk-form4_1717706029.xml · derivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,336 Underlying: Ordinary Shares · 8,336 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 2,084 on June 4, 2025; 2,084 on June 4, 2026; 2,084 on June 4, 2027 and 2,084 on June 5, 2028. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:33 UTC |
Madsen JuliaSenior VP, Life Sciences
|
GrantOrdinary Shares | 1,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-027069 · wk-form4_1717706029.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,671 F1 · balance_after: As of June 4, 2024, 4,483 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 1, 2024; 144 on October 1, 2024; 578 on June 2, 2025; 352 on June 2, 2025; 360 on June 2, 2025; 542 on June 4, 2025; 144 on October 1, 2025; 578 on June 1, 2026; 352 on June 2, 2026; 542 on June 4, 2026 and 542 on June 4, 2027. Read SEC document |
| June 04, 2024 Filed Jun 6, 2024 20:31 UTC |
Fraser Mary ClareSVP & Chief HRO
|
GrantEmployee Stock Option (right to buy) · Derivative | 10,456 | $0.00 Strike: $251.34 | $0.00 |
DisclosureSEC source: 0001628280-24-027056 · wk-form4_1717705871.xml · derivative · entry 2 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,456 Underlying: Ordinary Shares · 10,456 shares Expires 2034-06-04 F2 · derivative.exercise_date: This option becomes exercisable as follows: 2,614 on June 4, 2025; 2,614 on June 4, 2026; 2,614 on June 4, 2027 and 2,614 on June 5, 2028 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.